1 |
Zhao F, Wang X, Zhu W, Zhao D, Ye C, Guo Y, Dou Y. Low-dose pleiotropic radiosensitive nanoformulations for three-pronged radiochemotherapy of hypoxic brain glioblastoma under BOLD/DWI monitoring. Cancer Nano 2023;14:8. [DOI: 10.1186/s12645-023-00159-w] [Reference Citation Analysis]
|
2 |
Cui J, Wang X, Li J, Zhu A, Du Y, Zeng W, Guo Y, Di L, Wang R. Immune Exosomes Loading Self-Assembled Nanomicelles Traverse the Blood-Brain Barrier for Chemo-immunotherapy against Glioblastoma. ACS Nano 2023. [PMID: 36626296 DOI: 10.1021/acsnano.2c10219] [Reference Citation Analysis]
|
3 |
Allami P, Heidari A, Rezaei N. The role of cell membrane-coated nanoparticles as a novel treatment approach in glioblastoma. Front Mol Biosci 2022;9:1083645. [PMID: 36660431 DOI: 10.3389/fmolb.2022.1083645] [Reference Citation Analysis]
|
4 |
Jiang Z, Yang X, Ainiwaer M, Chen F, Liu J. Recent Clinical and Preclinical Advances in External Stimuli-Responsive Therapies for Head and Neck Squamous Cell Carcinoma. J Clin Med 2022;12. [PMID: 36614974 DOI: 10.3390/jcm12010173] [Reference Citation Analysis]
|
5 |
Wang L, Shi Y, Jiang J, Li C, Zhang H, Zhang X, Jiang T, Wang L, Wang Y, Feng L. Micro-Nanocarriers Based Drug Delivery Technology for Blood-Brain Barrier Crossing and Brain Tumor Targeting Therapy. Small 2022;18:e2203678. [PMID: 36103614 DOI: 10.1002/smll.202203678] [Reference Citation Analysis]
|
6 |
Wood H. New local therapy strategies for brain tumours. Nat Rev Neurol 2022. [PMID: 35945457 DOI: 10.1038/s41582-022-00710-0] [Reference Citation Analysis]
|